Calculus Capital
Finance · United Kingdom · 11-50 Employees
View Company Info for Free
Overview
Headquarters
12 Conduit St, London, Greater London, W...Phone Number
+44 2074934940Website
www.calculuscapital.comRevenue
<$5 MillionStock Symbol
CLCIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
3
1
2
2
1
1
About Calculus Capital
Calculus Capital is a Londonbased investment manager specializing in taxefficient growth capital for UK smaller companies. It manages venture capital trusts (VCTs), enterprise investment scheme (EIS) funds, and inheritance tax solutions that invest in highgrowth technology, healthcare, and creativeindustries businesses, giving private investors access to diversified portfolios of unlisted and AIMquoted UK companies.Explore more
Calculus Capital Org Chart
OW
Assistant Director, Sales & Marketing
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Calculus Capital your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Calculus Capital is spiking on competitors!
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Calculus Capital launches new products
Congratulate Masked Content for being promoted to Masked Content at Calculus Capital
Funding: Get notified immidiatlly once Calculus Capital has new funding data
Earning: See what the market has to say on Calculus Capital recently announced quarterly report
Check if Calculus Capital has recently received funding, and reach out quickly before it becomes old news!
Click to see if Calculus Capital had a recent Job posting/layoffs
Calculus Capital, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Calculus Capital
Compare insights from companies similar to Calculus Capital, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Calculus Capital is experiencing very low activity levels compared to other companies in the Finance sector.
What does this means?
Calculus Capital is drawing exceptional interest within the Finance industry, suggesting notable developments or strong market momentum, learn more about Calculus Capital.
Calculus Capital Tech Stack
A closer look at the technologies used by Calculus Capital
Most Recent Scoops
Project
Spending/Investment
Project
Spending/Investment
Project
Spending/Investment
Project
Spending/Investment
Project
Spending/Investment
Calculus Capital News & Media
Axol Bioscience Raises £3.2M In Funding
Axol Bioscience Ltd., a Cambridge, England, UK-based provider of iPSC-derived cells, media, and characterization services for life science discovery, raised £3.2m GBP (circa $4.2m USD). The round, the extension of its previous funding round, bringing the total raised to £7m GBP (circa $9.2m USD) – was led by existing investors Calculus Capital, Par Equity and Scottish Enterprise, […] The post Axol Bioscience Raises £3.2M In Funding appeared first on FinSMEs.Invizius Announces Successful Series A Financing to Develop Anti-Inflammatory Treatment for Haemodialysis
MOTHERWELL, Scotland, May 6, 2021 /PRNewswire/ -- Invizius Limited ("Invizius"), a biotechnology company developing treatments to suppress unwanted innate immune responses, today announces that it has closed Series A financing of £5.3 million. The financing was led by existing investors...Calculus VCT boosted by Genedrive, Mologic and other British biotechs tackling coronavirus
The real worth of Britain’s biotechnology sector is starting to be recognised thanks to the need to treat and diagnose coronavirus, according to Calculus VCT Plc’s (LON:CLC) manager John Glencross. Four of Calculus’s portfolio companies are working on treatments or products directly related to the virus. Two of these are private companies, but its two listed groups have seen their respective share prices soar recently. Glencross said its investee companies’ ability to pivot quickly to
Read more news
Top Finance Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Calculus Capital
Sign Up For FreeTo access detailed company insights
Calculus Capital is a Londonbased investment manager specializing in taxefficient growth capital for UK smaller companies. It manages venture capital trusts (VCTs), enterprise investment scheme (EIS) funds, and inheritance tax solutions that invest in highgrowth technology, healthcare, and creativeindustries businesses, giving private investors acc... Read More
